Buddy Carter actually said...
Wow. We need to fix that.
Context
Carter emphasizes the need to address loopholes in FDA inspections for bulk API products.
10/29/2019
Carter emphasizes the need to address loopholes in FDA inspections for bulk API products.
10/29/2019